Prognostic Value of Pretreatment Serum Inflammatory Markers in Patients Receiving Radiation therapy for Oropharyngeal Cancer (OPC)

被引:0
|
作者
Kanwar, A. [1 ]
Hayes, A. J. [2 ]
Mohamed, A. S. R. [3 ]
French, C. C. [4 ]
Gunn, G. B. [3 ]
Beadle, B. M. [3 ]
Phan, J. [3 ]
Skinner, H. D. [3 ]
Lai, S. [3 ]
Kies, M. S. [3 ]
Weber, R. S. [3 ]
Morrison, W. H. [3 ]
Rosenthal, D. I. [3 ]
Fuller, C. D. [3 ]
Garden, A. S. [3 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA
[2] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas Houston, Med Sch Houston, Houston, TX USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 04期
关键词
D O I
10.1016/j.ijrobp.2015.12.315
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
326
引用
收藏
页码:958 / 958
页数:1
相关论文
共 50 条
  • [21] Pretreatment Complete Blood Count Improves Prognostic Model Survival Prediction in Oropharyngeal Cancer Patients Treated With Radiation Therapy
    Mohamed, A. S. R.
    Shoultz-Henley, S.
    Garden, A. S.
    Sheu, T.
    Kroll, M.
    Rosenthal, D. I.
    Gunn, G. B.
    Phan, J.
    Lai, S.
    Kies, M. S.
    Gold, K. A.
    Sturgis, E. M.
    Fuller, C. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 964 - 964
  • [22] The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
    Poetsch, Nina
    Sturdza, Alina
    Aust, Stefanie
    Polterauer, Stephan
    Grimm, Christoph
    Schwameis, Richard
    Poetter, Richard
    Koelbl, Heinz
    Reinthaller, Alexander
    Seebacher, Veronika
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 430 - 440
  • [23] Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy
    Hernberg, M
    MEDICAL ONCOLOGY, 1999, 16 (03) : 145 - 153
  • [24] Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy
    Micaela Hernberg
    Medical Oncology, 1999, 16 : 145 - 153
  • [25] Prognostic value of several inflammatory markers in pancreatic cancer patients.
    Inoue, Dal
    Yamada, Ikuhiro
    Ozaka, Masato
    Matsuyama, Masato
    Takano, Kouichi
    Ishii, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
    Yao, Minya
    Liu, Yu
    Jin, Hailong
    Liu, Xiaojiao
    Lv, Kezhen
    Wei, Haiyan
    Du, Chengyong
    Wang, Shuqian
    Wei, Bajin
    Fu, Peifen
    ONCOTARGETS AND THERAPY, 2014, 7 : 1743 - 1752
  • [27] Prognostic Value of Inflammatory Markers in Patients with Head and Neck Cancer.
    Mrochem-Kwarciak, J.
    Rutkowski, T.
    Wygoda, A.
    Chmura, A.
    Skladowski, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S370 - S370
  • [28] Prognostic value of serum markers for prostate cancer
    Stenman, UH
    Abrahamsson, PA
    Aus, G
    Lilja, H
    Bangma, C
    Hamdy, FC
    Boccon-Gibod, L
    Ekman, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 : 64 - 81
  • [29] The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy
    Bever, Katherine M.
    Sugar, Elizabeth A.
    Bigelow, Elaine
    Sharma, Rajni
    Laheru, Daniel
    Wolfgang, Christopher L.
    Jaffee, Elizabeth M.
    Anders, Robert A.
    De Jesus-Acosta, Ana
    Zheng, Lei
    HPB, 2015, 17 (04) : 292 - 298
  • [30] Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy
    Tomasik, Bartlomiej
    Papis-Ubych, Anna
    Stawiski, Konrad
    Fijuth, Jacek
    Kedzierawski, Piotr
    Sadowski, Jacek
    Stando, Rafal
    Bibik, Robert
    Graczyk, Lukasz
    Latusek, Tomasz
    Rutkowski, Tomasz
    Fendler, Wojciech
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (05): : 1237 - 1249